Breaking News
0

Nanobiotix: Clinical Trail Starts For Liver Cancer Treatment

By Edison Stock MarketsJul 08, 2015 07:31AM ET
www.investing.com/analysis/nanobiotix-257642
Nanobiotix: Clinical Trail Starts For Liver Cancer Treatment
By Edison   |  Jul 08, 2015 07:31AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

NBTXR3 clinical trial starts in liver indications
Nanobiotix (PARIS:NANOB) has been granted approval in France to commence pilot clinical development with NBTXR3 for the treatment of liver cancers, allowing the start of a Phase I/II study in line with expected timelines. Liver cancers (including both primary and liver metastases) represent the next indications for NBTXR3, with trials in soft tissue sarcoma (STS), head and neck (H&N) cancer and rectal cancer ongoing. Our valuation is €505m.

Nanobiotix
Nanobiotix

The Phase I/II liver cancers trial will include both primary liver cancer and liver metastases and will explore both intra-lesion and intra-arterial dosing in Phase I, with Phase II in three groups (liver metastases and hepatocellular carcinoma/HCC, both with and without intrahepatic thrombosis) and efficacy measured by response rate, progression-free (PFS) and overall survival (OS), in addition to safety. We believe initial data could become available during 2016. If positive, we assume pivotal development could start in 2017 and forecast initial launches in 2021.

The most common primary liver cancer is HCC, although incidence is much lower in the US and Europe than in Asia (30,000 new cases in the US per year compared to 466,000 in Eastern Asia; source: GLOBOCAN 2012). Liver metastases arise from the spread of other primary cancers (such as colorectal, breast and lung cancer). In colorectal cancer alone there are nearly 150k new cases in the US each year, of which c 50% develop hepatic metastases; hence liver metastases forms the bulk of our €500m US/EU peak liver cancers sales.

To Read the Entire Report Please Click on the pdf File Below

Nanobiotix: Clinical Trail Starts For Liver Cancer Treatment
 

Related Articles

Nanobiotix: Clinical Trail Starts For Liver Cancer Treatment

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email